For instance, docetaxel treatment increased levels of CK18-Asp396 in the serum of breast cancer patients, indicating apoptotic death of tumor cells, while cyclophosphamide/epirubicin/5-fluorouracil treatment increased total CK18 levels, indicating necrotic death of tumor cells [13]. This evidence concerns the gene KRT18 and breast cancer.